Functional food for pregnant, lactating women and in perinatal nutrition: A role for dietary fibres?

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 12, Issue 6, 2009, Pages 565-574

  Champ, Martine ^a,b   Hoebler, Christine ^a  

^a Universite de Nantes   (France)

^b HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGOSACCHARIDE; PREBIOTIC AGENT;

ARTIFICIAL MILK; BREAST FEEDING; CONSTIPATION; COUNSELING; DIET SUPPLEMENTATION; DIETARY FIBER; FUNCTIONAL FOOD; GASTROINTESTINAL DISEASE; HUMAN; LACTATION; MILK; NUTRITION; OBESITY; PERINATAL PERIOD; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; REVIEW; RISK ASSESSMENT;

BREAST FEEDING; DIETARY FIBER; DIETARY SUPPLEMENTS; FEMALE; FUNCTIONAL FOOD; GASTROINTESTINAL DISEASES; HUMANS; INFANT; INFANT FORMULA; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INFANT, NEWBORN; LACTATION; METABOLIC DISEASES; MILK, HUMAN; OLIGOSACCHARIDES; PREBIOTICS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA;

EID: 70350135471     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e328331b4aa     Document Type: Review

References (90)

1. Walker A. Crude fibre, bowel motility, and pattern of diet. S Afr Med J 1961; 35:114-115.
2. Burkitt D. Some diseases characteristic of modern Western civilization. Br Med J 1973; 1:274-278.
3. Dwyer J,Goldin B, Gorbach S, Patterson J. Drug therapy reviews: dietary fiber and fiber supplements in the therapy of gastrointestinal disorders. Am J Hosp Pharm 1978; 35:278-287. (Pubitemid 8287718)
4. Young J. European market developments in prebiotic-and probiotic-contain-ing foodstuffs. Br J Nutr 1998; 80:S231-S233.
5. Levy A, Stokes R. Effects of a health promotion advertising campaign on sales of ready-to-eat cereals. Public Health Rep 1987; 102:398-403.
6. AFSSA. Effects of probiotics and prebiotics on flora and immunity in adults. February 2005. http://www.afssa.fr/Documents/NUT-Ra-Preprobiotiq.pdf.
7. Mellen P, Liese A, Tooze J, et al. Whole-grain intake and carotid artery atherosclerosis in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study. Am J Clin Nutr 2007; 85:1495-1502.
8. Flight I, Clifton P. Cereal grains and legumes in the prevention of coronary heart disease and stroke: a review of the literature. Eur J Clin Nutr 2006; 60:1145-1159.
9. Liu S, Manson J, Lee I, et al. Fruit and vegetable intake and risk of cardiovascular disease: the Women's Health Study. Am J Clin Nutr 2000; 72:922-928.
10. Talati R, Baker W, Pabilonia M, et al. The effects of barley-derived soluble fiber on serum lipids. Ann Fam Med 2009; 7:157-163.
11. Brighenti F. Dietary fructans and serum triacylglycerols: a meta-analysis of randomized controlled trials. J Nutr 2007; 137:S2552S-S2556.
12. Pittler M, Ernst E. Guar gum for body weight reduction: meta-analysis of randomized trials. Am J Med 2001; 110:724-730.
13. Brown L, RosnerB, Willett W, Sacks F. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 1999; 69:30-42.
14. Olson B, Anderson S, Becker M, et al. Psyllium-enriched cereals lower blood total cholesterol and LDL cholesterol, but not HDL cholesterol, in hyperch-olesterolemic adults: results of a meta-analysis. J Nutr 1997; 127:1973-1980.
15. Champ M, Langkilde A, Brouns F, et al. Advances in dietary fibre characterisation. 2. Consumption, chemistry, physiology and measurement of resistant starch; implications for health and food labelling. Nutr Res Rev 2003; 16:143-161.
16. Mann J, Cummings J. Possible implications for health of the different definitions of dietary fibre. Nutr Metab Cardiovasc Dis 2009; 19:226-229.
17. Cani P, Possemiers S, Van de Wiele T, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009; 58P:1092-1093.
18. Macfarlane S, Macfarlane G, Cummings J. Review article: prebiotics in the gastrointestinal tract. Aliment Pharmacol Ther 2006; 24:701-714.
19. Flamm G, Glinsmann W, Kritchevsky D, et al. Inulin and oligofructose as dietary fiber: a review of the evidence. Crit Rev Food Sci Nutr 2001; 41:353-362.
20. Picciano M. Pregnancy and lactation: physiological adjustments, nutritional requirements and the role of dietary supplements. J Nutr 2003; 133:1997S-2002S.
21. Sunehag A, Tigas S, Haymond M. Contribution of plasma galactose and glucose to milk lactose synthesis during galactose ingestion. J Clin Endocrinol Metab 2003; 88:225-229.
22. Baron T, Ramirez B, Richter J. Gastrointestinal motility disorders during pregnancy. Ann Intern Med 1993; 118:366-375.
23. Gunderson E, Abrams B. Epidemiology of gestational weight gain and body weight changes after pregnancy. Epidemiol Rev 2000; 22:261-274.
24. Schmitt N, Nicholson W, Schmitt J. The association of pregnancy and the development of obesity-results of a systematic review and meta-analysis on the natural history of postpartum weight retention. Int J Obes (Lond) 2007; 31:1642-1651.
25. Frischknecht F, Bruhwiler H, Raio L, Luscher K. Changes in prepregnancy weight and weight gain during pregnancy: retrospective comparison between 1986 and 2004. Swiss Med Wkly 2009; 139:52-55.
26. Kinnunen T, Pasanen M, Aittasalo M, et al. Preventing excessive weight gain during pregnancy: a controlled trial in primary healthcare. Eur J Clin Nutr 2007; 61:884-891.
27. Kinnunen T, Pasanen M, Aittasalo M, et al. Reducing postpartum weight retention: a pilot trial in primary healthcare. Nutr J 2007; 6:21.
28. Liu N, Mao L, Sun X, et al. The effect of health and nutrition education intervention on women's postpartum beliefs and practices: a randomized controlled trial. BMC Public Health 2009; 9:45.
29. Ley R, Turnbaugh P, Klein S, Gordon J. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444:1022-1023.
30. Duncan S, Lobley G, Holtrop G, et al. Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes (Lond) 2008; 32:1720-1724.
31. Cani P, Delzenne N. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 2009; 15:1546-1558.
32. DiBaise JK, Zhang H, Crowell MD, et al. Gut microbiota and its possible relationship with obesity. Mayo Clin Proc 2008; 83:460-469.
33. Laitinen K, Poussa T, Isolauri E. Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. Br J Nutr 2009; 101:1679-1687.
34. Cani P. Gut microbiota and pregnancy, a matter of inner life. Br J Nutr 2009; 101:1579-1580.
35. Kuhle S, Allen A, Veugelers P. Perinatal and childhood risk factors for overweight in a provincial sample of Canadian grade 5 students. Int J Pediatr Obes 2009; 28:1-9.
36. Walker L, Hoke M, Brown A. Risk factors for excessive or inadequate gestational weight gain among Hispanic women in a U.S.-Mexico border state. J Obstet Gynecol Neonatal Nurs 2009; 38:418-429.
37. Dabelea D, Snell-Bergeon J, Hartsfield C, et al. Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 2005; 28:579-584.
38. Retnakaran R, Qi Y, Sermer M, et al. Glucose intolerance in pregnancy and future risk of prediabetes or diabetes. Diabetes Care 2008; 31: 2026-2031.
39. Carpenter M. Gestational diabetes, pregnancy hypertension, and late vascular disease. Diabetes Care 2007; 30 (Suppl 2):S246-S250.
40. Salmeron J, Manson J, Stampfer M, et al. Dietary fiber, glycemic load, and risk of noninsulin-dependent diabetes mellitus in women. J Am Med Assoc 1997; 277:472-477.
41. Tieu J, CrowtherCA, Middleton P. Dietary advices in pregnancy for preventing gestational diabetes mellitus. Cochrane Database Syst Rev 2008; CD006674:1-14.
42. Moses R, Luebcke M, Davis W, et al. Effect of a low-glycemic-index diet during pregnancy on obstetric outcomes. Am J Clin Nutr 2006; 84:807-812.
43. Radesky J, Oken E, Rifas-Shiman S, et al. Diet during early pregnancy and development of gestational diabetes. Paediatr Perinat Epidemiol 2008; 22:47-59.
44. Qiu C, Coughlin K, Frederick I, et al. Dietary fiber intake in early pregnancy and risk of subsequent preeclampsia. Am J Hypertens 2008; 21:903-909.
45. Bradley C, Kennedy C, Turcea A, et al. Constipation in pregnancy: prevalence, symptoms, and risk factors. Obstet Gynecol 2007; 110:1351-1357.
46. Prather C. Pregnancy-related constipation. Curr Gastroenterol Rep 2004; 6:402-404.
47. Jewell D, Young G. Interventions for treating constipation in pregnancy. Cochrane Database Syst Rev 2001:CD001142.
48. Anderson A, Whichelow M. Constipation during pregnancy: dietary fibre intake and the effect of fibre supplementation. Hum Nutr Appl Nutr 1985; 39:202-207.
49. Xu J, Mahowald M, Ley R, et al. Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol 2007; 5:e156.
50. Young V, Schmidt T. Overview of the gastrointestinal microbiota. Adv Exp Med Biol 2008; 635:29-40.
51. Adlerberth I. Factors influencing the establishment of the intestinal microbiota in infancy. Nestle Nutr Workshop Ser Pediatr Program 2008; 62:13-29; discussion-33.
52. Brunser O, Figueroa G, Gotteland M, et al. Effects of probiotic or prebiotic supplemented milk formulas on fecal microbiota composition of infants. Asia Pac J Clin Nutr 2006; 15:368-376.
53. Palmer C, BikE, DiGiulio D, et al. Development of the human infant intestinal microbiota. PLoS Biol 2007; 5:e177.
54. Newburg D. Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans. J Anim Sci 2009; 87: 26-34.
55. Coppa G, Zampini L, Galeazzi T, Gabrielli O. Prebiotics in human milk: a review. Dig Liver Dis 2006; 38 (Suppl 2):S291-S294.
56. Newburg D, Ruiz-Palacios G, Morrow A. Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr 2005; 25:37-58.
57. Kuntz S, Rudloff S, Kunz C. Oligosaccharides from human milk influence growth-related characteristics of intestinally transformed and nontransformed intestinal cells. Br J Nutr 2008; 99:462-471.
58. Kuntz S, Kunz C, Rudloff S. Oligosaccharides from human milk induce growth arrest via G2/M by influencing growth-related cell cycle genes in intestinal epithelial cells. Br J Nutr 2009; 101:1306-1315.
59. Shkoporov A, Khokhlova E, Kulagina E, et al. Application of several molecular techniques to study numerically predominant Bifidobacterium spp. and Bacteroidales order strains in the feces of healthy children. Biosci Biotechnol Biochem 2008; 72:742-748.
60. Perez P, Doré J, Leclerc M, et al. Bacterial imprinting of the neonatal immune system: lessons from maternal cells? Pediatrics 2007; 119:e724-e732.
61. Monto A. Epidemiology of viral respiratory infections. Am J Med 2002; 112 (Suppl 6A):4S-12S.
62. Adlerberth I, Wold A. Establishment of the gut microbiota in Western infants. Acta Paediatr 2009; 98:229-238.
63. Ogra P, Welliver RS. Effects of early environment on mucosal immunologic homeostasis, subsequent immune responses and disease outcome. Nestle Nutr Workshop Ser Pediatr Program 2008; 61:145-181.
64. Boehm G, Stahl B, Jelinek J, et al. Prebiotic carbohydrates in human milk and formulas. Acta Paediatr Suppl 2005; 94:18-21.
65. Macfarlane G, Steed H, Macfarlane S. Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J Appl Microbiol 2008; 104:305-344.
66. Bakker-Zierikzee A, Alles M, Knol J, et al. Effects of infant formula containing a mixture of galacto-and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life. Br J Nutr 2005; 94:783-790.
67. Bruzzese E, Volpicelli M, Squeglia V, et al. A formula containing galacto-and fructo-oligosaccharides prevents intestinal and extra-intestinal infections: an observational study. Clin Nutr 2009; 28:156-161.
68. Arslanoglu S, Moro G, Boehm G. Early supplementation of prebiotic oligo-saccharides protects formula-fed infants against infections during the first 6 months of life. J Nutr 2007; 137:2420-2424.
69. Scholtens P, Alliet P, Raes M, et al. Fecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides. J Nutr 2008; 138:1141-1147.
70. van Hoffen E, Ruiter B, Faber J, et al. A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy. Allergy 2009; 64:484-487.
71. Veereman G. Pediatric applications of inulin and oligofructose. J Nutr 2007; 137:2585S-2589S.
72. Barrat E, Michel C, Poupeau G, et al. Supplementation with galactooligo-saccharides and inulin increases bacterial translocation in artificially reared newborn rats. Pediatr Res 2008; 64:34-39.
73. Westerbeek E, van Elburg R, van den Berg A, et al. Design of a randomised controlled trial on immune effects of acidic and neutral oligosaccharides in the nutrition of preterm infants: carrot study. BMC Pediatr 2008; 8:46.
74. Morais M, Jacob C. The role of probiotics and prebiotics in pediatric practice. J Pediatr (Rio J) 2006; 82:S189-S197.
75. Fukushima Y, Kawata Y, Hara H, et al. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 1998; 42:39-44.
76. Rautava S, Arvilommi H, Isolauri E. Specific probiotics in enhancing maturation of IgA responses in formula-fed infants. Pediatr Res 2006; 60:221-224.
77. Kaila M, Isolauri E, Soppi E, et al. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 1992; 32:141-144.
78. Holt P, Jones C. The development of the immune system during pregnancy and early life. Allergy 2000; 55:688-697.
79. Rautava S, Salminen S, Isolauri E. Specific probiotics in reducing the risk of acute infections in infancy: a randomised, double-blind, placebo-controlled study. Br J Nutr 2009; 101:1722-1726.
80. Boehm G, Moro G. Structural and functional aspects of prebiotics used in infant nutrition. J Nutr 2008; 138:1818S-1828S.
81. Nakamura N, Gaskins H, Collier C, et al. Molecular ecological analysis of fecal bacterial populations from term infants fed formula supplemented with selected blends of prebiotics. Appl Environ Microbiol 2009; 75:1121-1128.
82. Magne F, Hachelaf W, Suau A, et al. Effects on faecal microbiota of dietary and acidic oligosaccharides in children during partial formula feeding. J Pediatr Gastroenterol Nutr 2008; 46:580-588.
83. Kukkonen K, Savilahti E, Haahtela T, et al. Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics 2008; 122: 8-12.
84. Victora C, Adair L, Fall C, et al. Maternal and child undernutrition: consequences for adult health and human capital. Lancet 2008; 371:340-357.
85. McMillen I, Robinson J. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 2005; 85:571-633.
86. Clausen T, Mathiesen E, Hansen T, et al. High prevalence of type 2 diabetes and prediabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care 2008; 31:340-346.
87. Fathallah H, Weinberg R, Galperin Y, et al. Role of epigenetic modifications in normal globin gene regulation and butyrate-mediated induction of fetal hemoglobin. Blood 2007; 110:3391-3397.
88. Kaneda R, Ueno S, Yamashita Y, et al. Genome-wide screening for target regions of histone deacetylases in cardiomyocytes. Circ Res 2005; 97:210-218.
89. Fåk F, Ahrné S, Linderoth A, et al. Age-related effects of the probiotic bacterium Lactobacillus plantarum 299v on gastrointestinal function in suckling rats. Dig Dis Sci 2008; 53:664-671.
90. Shadid R, Haarman M, Knol J, et al. Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity-a randomized, double-blind, placebo-controlled study. Am J Clin Nutr 2007; 86:1426-1437.